221 related articles for article (PubMed ID: 35637481)
1. Antibiofilm and staphyloxanthin inhibitory potential of terbinafine against Staphylococcus aureus: in vitro and in vivo studies.
Askoura M; Yousef N; Mansour B; Yehia FAA
Ann Clin Microbiol Antimicrob; 2022 May; 21(1):21. PubMed ID: 35637481
[TBL] [Abstract][Full Text] [Related]
2. Celastrol mitigates staphyloxanthin biosynthesis and biofilm formation in Staphylococcus aureus via targeting key regulators of virulence; in vitro and in vivo approach.
Yehia FAA; Yousef N; Askoura M
BMC Microbiol; 2022 Apr; 22(1):106. PubMed ID: 35421933
[TBL] [Abstract][Full Text] [Related]
3. Hesperidin inhibits biofilm formation, virulence and staphyloxanthin synthesis in methicillin resistant Staphylococcus aureus by targeting SarA and CrtM: an in vitro and in silico approach.
Vijayakumar K; Muhilvannan S; Arun Vignesh M
World J Microbiol Biotechnol; 2022 Jan; 38(3):44. PubMed ID: 35064842
[TBL] [Abstract][Full Text] [Related]
4. Dehydrosqualene Desaturase as a Novel Target for Anti-Virulence Therapy against
Gao P; Davies J; Kao RYT
mBio; 2017 Sep; 8(5):. PubMed ID: 28874472
[No Abstract] [Full Text] [Related]
5. Zinc oxide nanoparticles reduce biofilm formation, synergize antibiotics action and attenuate Staphylococcus aureus virulence in host; an important message to clinicians.
Abdelghafar A; Yousef N; Askoura M
BMC Microbiol; 2022 Oct; 22(1):244. PubMed ID: 36221053
[TBL] [Abstract][Full Text] [Related]
6. Glyceryl trinitrate blocks staphyloxanthin and biofilm formation in
Abbas HA; Elsherbini AM; Shaldam MA
Afr Health Sci; 2019 Mar; 19(1):1376-1384. PubMed ID: 31148964
[TBL] [Abstract][Full Text] [Related]
7. Small-molecule compound SYG-180-2-2 attenuates
Rao L; Xu Y; Shen L; Wang X; Zhao H; Wang B; Zhang J; Xiao Y; Guo Y; Sheng Y; Cheng L; Song Z; Yu F
Front Cell Infect Microbiol; 2022; 12():1008289. PubMed ID: 36310881
[TBL] [Abstract][Full Text] [Related]
8. The promising anti-virulence activity of candesartan, domperidone, and miconazole on Staphylococcus aureus.
El-Ganiny AM; Gad AI; El-Sayed MA; Shaldam MA; Abbas HA
Braz J Microbiol; 2022 Mar; 53(1):1-18. PubMed ID: 34773629
[TBL] [Abstract][Full Text] [Related]
9.
Vila T; Kong EF; Ibrahim A; Piepenbrink K; Shetty AC; McCracken C; Bruno V; Jabra-Rizk MA
Virulence; 2019 Dec; 10(1):625-642. PubMed ID: 31280653
[TBL] [Abstract][Full Text] [Related]
10. Staphyloxanthin inhibitory potential of thymol impairs antioxidant fitness, enhances neutrophil mediated killing and alters membrane fluidity of methicillin resistant Staphylococcus aureus.
Valliammai A; Selvaraj A; Muthuramalingam P; Priya A; Ramesh M; Pandian SK
Biomed Pharmacother; 2021 Sep; 141():111933. PubMed ID: 34328107
[TBL] [Abstract][Full Text] [Related]
11. Protective Effect of the Golden Staphyloxanthin Biosynthesis Pathway on Staphylococcus aureus under Cold Atmospheric Plasma Treatment.
Yang Y; Wang H; Zhou H; Hu Z; Shang W; Rao Y; Peng H; Zheng Y; Hu Q; Zhang R; Luo H; Rao X
Appl Environ Microbiol; 2020 Jan; 86(3):. PubMed ID: 31704682
[No Abstract] [Full Text] [Related]
12. Attenuating the virulence of the resistant superbug Staphylococcus aureus bacteria isolated from neonatal sepsis by ascorbic acid, dexamethasone, and sodium bicarbonate.
Saleh MM; Yousef N; Shafik SM; Abbas HA
BMC Microbiol; 2022 Nov; 22(1):268. PubMed ID: 36348266
[TBL] [Abstract][Full Text] [Related]
13. Diclofenac mitigates virulence of multidrug-resistant Staphylococcus aureus.
Abbas HA; Atallah H; El-Sayed MA; El-Ganiny AM
Arch Microbiol; 2020 Dec; 202(10):2751-2760. PubMed ID: 32737541
[TBL] [Abstract][Full Text] [Related]
14. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence.
Liu CI; Liu GY; Song Y; Yin F; Hensler ME; Jeng WY; Nizet V; Wang AH; Oldfield E
Science; 2008 Mar; 319(5868):1391-4. PubMed ID: 18276850
[TBL] [Abstract][Full Text] [Related]
15. Virulence of endemic nonpigmented northern Australian Staphylococcus aureus clone (clonal complex 75, S. argenteus) is not augmented by staphyloxanthin.
Tong SY; Sharma-Kuinkel BK; Thaden JT; Whitney AR; Yang SJ; Mishra NN; Rude T; Lilliebridge RA; Selim MA; Ahn SH; Holt DC; Giffard PM; Bayer AS; Deleo FR; Fowler VG
J Infect Dis; 2013 Aug; 208(3):520-7. PubMed ID: 23599317
[TBL] [Abstract][Full Text] [Related]
16. Carvacrol Targets SarA and CrtM of Methicillin-Resistant
Selvaraj A; Valliammai A; Muthuramalingam P; Priya A; Suba M; Ramesh M; Karutha Pandian S
ACS Omega; 2020 Dec; 5(48):31100-31114. PubMed ID: 33324819
[TBL] [Abstract][Full Text] [Related]
17. Vitexin alters Staphylococcus aureus surface hydrophobicity to obstruct biofilm formation.
Das MC; Samaddar S; Jawed JJ; Ghosh C; Acharjee S; Sandhu P; Das A; Daware AV; De UC; Majumdar S; Das Gupta SK; Akhter Y; Bhattacharjee S
Microbiol Res; 2022 Oct; 263():127126. PubMed ID: 35914415
[TBL] [Abstract][Full Text] [Related]
18. Reserpine attenuates biofilm formation and virulence of Staphylococcus aureus.
Parai D; Banerjee M; Dey P; Mukherjee SK
Microb Pathog; 2020 Jan; 138():103790. PubMed ID: 31605761
[TBL] [Abstract][Full Text] [Related]
19. Small-Molecule Compound CY-158-11 Inhibits Staphylococcus aureus Biofilm Formation.
Shen L; Zhang J; Chen Y; Rao L; Wang X; Zhao H; Wang B; Xiao Y; Yu J; Xu Y; Shi J; Han W; Song Z; Yu F
Microbiol Spectr; 2023 Jun; 11(3):e0004523. PubMed ID: 37166296
[TBL] [Abstract][Full Text] [Related]
20. Anti-Pathogenic Efficacy and Molecular Targets of a Polyherbal Wound- Care Formulation (Herboheal) Against Staphylococcus aureus.
Patel P; Joshi C; Kothari V
Infect Disord Drug Targets; 2019; 19(2):193-206. PubMed ID: 30345928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
